Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
814 dias atrás
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1080 dias atrás
U.S. Dollar Falls Against Franc, Canadian Dollar
The U.S. dollar fell against the Swiss franc and the Canadian dollar in the New York session on Wednesday.
RTTNews
|
1h 1min atrás
Win Streak May Continue For Singapore Stock Market
The Singapore stock market has finished higher in back-to-back sessions, gathering more than 80 points or 1.8 percent along the way. The Straits Times Index now sits just beneath the 4,570-point plateau and it's expected to bounce higher again on Thursday.
RTTNews
|
1h 14min atrás
Japan Producer Prices Climb 2.7% On Year In October
Producer prices in Japan were up 2.7 percent on year in October, the Bank of Japan said on Thursday.
RTTNews
|
1h 19min atrás
Rebound Anticipated For Malaysia Stock Market
The Malaysia stock market on Wednesday ended the three-day winning streak in which it had risen more than 15 points or 1 percent. The Kuala Lumpur Composite Index now sits just above the 1,630-point plateau although it figures to bounce higher again on Thursday.
RTTNews
|
1h 44min atrás
Additional Support Predicted For Japan Stock Market
The Japan stock market has alternated between positive and negative finishes through the last five trading days since the end of the two-day slide in which it had plunged nearly 2,200 points or 4.2 percent. The Nikkei 225 now rests just above the 50,840-point plateau and it may tick higher again on Thursday.
RTTNews
|
1h 59min atrás
Win Streak May Continue For South Korea Shares
The South Korea stock market has tracked higher in three straight sessions, advancing almost 200 points or 5 percent in that span. The KOSPI sits just above the 4,150-point plateau and it's tipped to open in the green again on Thursday.
RTTNews
|
2h 14min atrás
